Management of biologics in oral surgery

Biologics have revolutionised the management of immune-mediated inflammatory disorders, and their growing use has resulted in increasing numbers of these patients presenting in oral surgery settings. While the efficacy of biologics has been well established, they are associated with numerous adverse...

Full description

Bibliographic Details
Main Authors: Mills Sophie, Ryan Patrick, Gaffney Karl
Format: Article
Language:English
Published: EDP Sciences 2023-01-01
Series:Journal of Oral Medicine and Oral Surgery
Subjects:
Online Access:https://www.jomos.org/articles/mbcb/full_html/2023/03/mbcb230091/mbcb230091.html
_version_ 1827792317801562112
author Mills Sophie
Ryan Patrick
Gaffney Karl
author_facet Mills Sophie
Ryan Patrick
Gaffney Karl
author_sort Mills Sophie
collection DOAJ
description Biologics have revolutionised the management of immune-mediated inflammatory disorders, and their growing use has resulted in increasing numbers of these patients presenting in oral surgery settings. While the efficacy of biologics has been well established, they are associated with numerous adverse effects. Several professional bodies have published recommendations on perioperative management of these agents to reduce complications. Currently no specific dental or oral surgery guidance exists. The aim of this paper is to review the current literature and guidance regarding the use of biologics in the perioperative period.
first_indexed 2024-03-11T18:00:13Z
format Article
id doaj.art-98c45d6fe5ea484b878eb82091099516
institution Directory Open Access Journal
issn 2608-1326
language English
last_indexed 2024-03-11T18:00:13Z
publishDate 2023-01-01
publisher EDP Sciences
record_format Article
series Journal of Oral Medicine and Oral Surgery
spelling doaj.art-98c45d6fe5ea484b878eb820910995162023-10-17T08:54:41ZengEDP SciencesJournal of Oral Medicine and Oral Surgery2608-13262023-01-012932810.1051/mbcb/2023025mbcb230091Management of biologics in oral surgeryMills Sophie0https://orcid.org/0000-0001-7400-124XRyan Patrick1Gaffney Karl2Department of Oral and Maxillofacial Surgery, Norfolk and Norwich University HospitalDepartment of Oral and Maxillofacial Surgery, Norfolk and Norwich University HospitalDepartment of Oral and Maxillofacial Surgery, Norfolk and Norwich University HospitalBiologics have revolutionised the management of immune-mediated inflammatory disorders, and their growing use has resulted in increasing numbers of these patients presenting in oral surgery settings. While the efficacy of biologics has been well established, they are associated with numerous adverse effects. Several professional bodies have published recommendations on perioperative management of these agents to reduce complications. Currently no specific dental or oral surgery guidance exists. The aim of this paper is to review the current literature and guidance regarding the use of biologics in the perioperative period.https://www.jomos.org/articles/mbcb/full_html/2023/03/mbcb230091/mbcb230091.htmlbiological productsinfectionsoral surgical proceduresoral surgerypostoperative complications
spellingShingle Mills Sophie
Ryan Patrick
Gaffney Karl
Management of biologics in oral surgery
Journal of Oral Medicine and Oral Surgery
biological products
infections
oral surgical procedures
oral surgery
postoperative complications
title Management of biologics in oral surgery
title_full Management of biologics in oral surgery
title_fullStr Management of biologics in oral surgery
title_full_unstemmed Management of biologics in oral surgery
title_short Management of biologics in oral surgery
title_sort management of biologics in oral surgery
topic biological products
infections
oral surgical procedures
oral surgery
postoperative complications
url https://www.jomos.org/articles/mbcb/full_html/2023/03/mbcb230091/mbcb230091.html
work_keys_str_mv AT millssophie managementofbiologicsinoralsurgery
AT ryanpatrick managementofbiologicsinoralsurgery
AT gaffneykarl managementofbiologicsinoralsurgery